JP2025511871A5 - - Google Patents
Info
- Publication number
- JP2025511871A5 JP2025511871A5 JP2024559436A JP2024559436A JP2025511871A5 JP 2025511871 A5 JP2025511871 A5 JP 2025511871A5 JP 2024559436 A JP2024559436 A JP 2024559436A JP 2024559436 A JP2024559436 A JP 2024559436A JP 2025511871 A5 JP2025511871 A5 JP 2025511871A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- subject
- ecm
- mbv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329319P | 2022-04-08 | 2022-04-08 | |
| US63/329,319 | 2022-04-08 | ||
| PCT/US2023/065525 WO2023196970A1 (en) | 2022-04-08 | 2023-04-07 | Matrix bound nanovesicles encapsulated in hydrogels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511871A JP2025511871A (ja) | 2025-04-16 |
| JP2025511871A5 true JP2025511871A5 (cg-RX-API-DMAC7.html) | 2026-04-14 |
Family
ID=88243848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559436A Pending JP2025511871A (ja) | 2022-04-08 | 2023-04-07 | ヒドロゲルに封入されたマトリックス結合ナノベシクル |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250228896A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4504223A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025511871A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250004752A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119072301A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023249793A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247619A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023196970A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025128639A1 (en) * | 2023-12-12 | 2025-06-19 | The Children's Medical Center Corporation | Hydrogels comprising protein-stabilized nanoparticles for extended release |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017227790B2 (en) * | 2016-03-02 | 2023-03-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Matrix bound nanovesicles and their use |
| CA3049990A1 (en) * | 2017-03-02 | 2018-09-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Extracellular matrix (ecm) hydrogel and soluble fraction thereof for the treatment of cancer |
| KR20210005942A (ko) * | 2018-05-03 | 2021-01-15 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | Il-33을 포함하는 매트릭스 결합 소포 (mbvs) 및 그 용도 |
| AU2020235627B2 (en) * | 2019-03-13 | 2026-01-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Acoustic extracellular matrix hydrogels and their use |
| CN116157138A (zh) * | 2020-09-11 | 2023-05-23 | 联邦高等教育系统匹兹堡大学 | 源自细胞外基质的最终灭菌的水凝胶或胶体悬浮液的制备方法及其用途 |
-
2023
- 2023-04-07 AU AU2023249793A patent/AU2023249793A1/en active Pending
- 2023-04-07 JP JP2024559436A patent/JP2025511871A/ja active Pending
- 2023-04-07 US US18/853,393 patent/US20250228896A1/en active Pending
- 2023-04-07 KR KR1020247037420A patent/KR20250004752A/ko active Pending
- 2023-04-07 WO PCT/US2023/065525 patent/WO2023196970A1/en not_active Ceased
- 2023-04-07 CA CA3247619A patent/CA3247619A1/en active Pending
- 2023-04-07 CN CN202380032308.1A patent/CN119072301A/zh active Pending
- 2023-04-07 EP EP23785671.1A patent/EP4504223A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klein et al. | Kaposi sarcoma complicating systemic lupus erythematosus treated with immunosuppression | |
| CH683965A5 (it) | Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici. | |
| JP2025511871A5 (cg-RX-API-DMAC7.html) | ||
| JP2018521086A (ja) | 硫酸デキストランの新しい使用 | |
| Valero et al. | Retinitis pigmentosa, hypertension, and uraemia in Werner's syndrome | |
| RU2430733C2 (ru) | Фармацевтическая композиция для лечения заболеваний предстательной железы (варианты) | |
| TW201002341A (en) | A therapeutic agent for lower urinary tract diseases and an improving agent for lower urinary tract symptoms | |
| Christensen et al. | Storage of polyvinylpyrrolidone (PVP) in tissues following long‐term treatment with a PVP‐containing vasopressin preparation | |
| JP2003523319A (ja) | 閉塞した生物学的管を開通するためのシステムと方法 | |
| JP2002512195A (ja) | Ｎ−アセチルグルコサミンの結腸投与による炎症性腸疾患用の組成物およびその治療 | |
| RU2364405C1 (ru) | Способ лечения воспалительных заболеваний кишечника | |
| Morita et al. | Triple bypass for multisystem smooth muscle dysfunction syndrome due to Arg179His ACTA2 mutation | |
| CA3065893A1 (en) | Compositions for the treatment of ischemic ulcers and stretch marks | |
| Wallach et al. | Cardiac disease and hypothyroidism: Complications induced by initial thyroid therapy | |
| Schiavone et al. | PRUNE BELLY SYNDROME: CASE REPORT OF A FAILED MANAGEMENT IN A LOW INCOME COUNTRY | |
| Barannikov et al. | APPLICATION OF ALGINATE POLYMER POLYSACCHARIDE HEMOSTATIC HYDROGEL FOR ONGOING ARTERIAL BLEEDING FROM PEPTIC ULCER OF GASTROENTEROANASTOMOSIS (A CLINICAL CASE) | |
| HINES | A form of polypoid colitis as a late stage of amebic dysentery | |
| EP3849514A1 (en) | A composition for use in the prevention and/or treatment of epistaxis | |
| WO2019169712A1 (zh) | 丁酸类化合物在促进组织内源性干细胞活化、增殖和分化中的应用 | |
| Cai | Transjugular Intrahepatic Portosystemic Shunt in Children with Cirrhosis of Unknown Origin: A Case Report and Literature Review | |
| Shaw | Organotherapy: Or, Treatment by Means of Preparations of Various Organs | |
| Vasile et al. | Large Pancreatic Pseudocyst Spontaneously Fistulized to the Duodenum | |
| RU2517163C2 (ru) | Способ лечения болевого синдрома при панкреатите | |
| Li et al. | An unpredictable gastrointestinal bleed | |
| Elhussieny et al. | Mitomycin-C as a Preventive Measure of Adhesion after Functional Endoscopic Sinus Surgery (FESS) |